Shares of Resverlogix Corp. (TSE:RVX – Get Free Report) passed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of C$0.06 and traded as low as C$0.06. Resverlogix shares last traded at C$0.06, with a volume of 1,000 shares traded.
Resverlogix Stock Performance
The company has a 50 day moving average of C$0.06 and a two-hundred day moving average of C$0.06. The stock has a market capitalization of C$13.85 million, a PE ratio of -1.00 and a beta of 0.71.
About Resverlogix
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
Read More
- Five stocks we like better than Resverlogix
- The How And Why of Investing in Oil Stocks
- 3 Defense Stocks Gaining From Budget and Interest Rate Pressures
- What is the Dogs of the Dow Strategy? Overview and Examples
- 3 Natural Gas Stocks Set to Thrive in This Winter’s Freeze
- Why Invest in High-Yield Dividend Stocks?
- Bullish on Athleisure? Here’s Why Lululemon Stock Shines
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
